PostDoc day

Nuno Arantes-Oliveira


Nuno Arantes-Oliveira is a life-science expert and serial entrepreneur. He is currently CEO of Coimbra Genomics S.A., a personalized medicine start-up which he co-founded in 2012 and for which he has raised a seed round of venture capital funding. Prior to that Nuno was President and CEO of Alfama, Inc., a drug development company he also co-founded, based in Boston and Lisbon, and focused on the development of a completely novel and powerful class of pharmaceutical compounds. Alfama was the first venture of its kind to be launched out of Portugal. Nuno is also President of P-BIO, Portugal’s Biotechnology Industry Organization (www.p-bio.org), and was until recently a Board member of the Health Cluster Portugal – the largest association of health-related entities in Portugal. After graduating from the University of Lisbon in 1997, Nuno entered the Gulbenkian Doctoral Program in Biology and Medicine. Sponsored by that Program and by the Portuguese Government, Nuno performed his graduate research at the University of California San Francisco (UCSF) under Professor Cynthia Kenyon. From 1998 to 2002 Nuno’s work shed light on the molecular mechanisms controlling lifespan and aging in higher organisms, and led to the publication of several papers in high-impact scientific journals, including three in Science. Nuno led the studies that achieved the longest lifespan extension ever produced in any living being up to that point.

From 2002 to 2005 Nuno was a post-doctoral fellow at the IN+ Center, an academic think tank within Lisbon’s Instituto Superior Técnico, where he studied entrepreneurship and innovation in the biotech industry. At the same time Nuno started ATGC Portugal, which became a leading technology transfer company in the country.

In 2005 Nuno founded Alfama, Inc. with an international group of reputed entrepreneurs and scientists, and with it raised over €14 million, mostly in venture capital funding. He set up the company’s headquarters in the United States, and later led the acquisition of its most direct competitor – the company hemoCORM Ltd, of London.

Nuno has received awards and decorations from various public and private entities in several countries. He has designed and executed major transactions and collaborations in Europe, North America, China and Africa. Represented by Nuno, Alfama was voted the “best start-up in Europe” in 2005, from among 300 contestants. Nuno is or has been an advisor to several organizations, including governments, foundations (COTEC, AAAS), academic centers (IPATIMUP, CEDOC) and technology-based start-ups, of which he occasionally becomes a shareholder.

Nuno is married to Sofia, a dentist and university professor. Together they have three children.